Tapestri Single-cell DNA Classic Hodgkin's Lymphoma Panel
While nearly 80% of Classic Hodgkin’s Lymphoma cases respond well to treatment, the lasting effects and lack of understanding of the root drives a need for a targeted approach. The key to outcome improvement is in understanding genetic diversity at the single-cell level. Uncover clonal evolution insights with precision; download the CHL Tapestri panel today.
Advance your understanding of the genetic heterogeneity underpinning Classic Hodgkin’s Lymphoma (CHL) by targeting 11 genes with 38 amplicons for single-cell sequencing. Covering a combination of oncogenes and tumor suppressor genes, this panel is designed to cover some of the most commonly mutated genes associated with CHL.